130 related articles for article (PubMed ID: 3179462)
21. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization.
Yu WP; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):169-83. PubMed ID: 8773737
[TBL] [Abstract][Full Text] [Related]
22. Swine hemoglobin as a potential source of artificial oxygen carriers, hemoglobin-vesicles.
Sakai H; Ng K; Li B; Sugimura N
Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):37-41. PubMed ID: 22992176
[TBL] [Abstract][Full Text] [Related]
23. The impact of polyethylene glycol conjugation on bovine hemoglobin's circulatory half-life and renal effects in a rabbit top-loaded transfusion model.
Conover CD; Gilbert CW; Shum KL; Shorr RG
Artif Organs; 1997 Aug; 21(8):907-15. PubMed ID: 9247180
[TBL] [Abstract][Full Text] [Related]
24. Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.
Chenari M; Norouzi M; Ghalichi L; Rezaee A; Yari A; Alavian SM; Jazayeri SM
J Med Virol; 2014 Nov; 86(11):1861-7. PubMed ID: 25132488
[TBL] [Abstract][Full Text] [Related]
25. Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation.
Chang TM; Powanda D; Yu WP
Artif Cells Blood Substit Immobil Biotechnol; 2003 Aug; 31(3):231-47. PubMed ID: 12906306
[TBL] [Abstract][Full Text] [Related]
26. Polymerized pyridoxylated hemoglobin: efficacy as an O2 carrier.
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Moss GS
J Trauma; 1986 Oct; 26(10):903-8. PubMed ID: 3772998
[TBL] [Abstract][Full Text] [Related]
27. Pyridoxylated hemoglobin solution as an oxygen carrier.
Alexander JW
Ann Surg; 1990 Apr; 211(4):381. PubMed ID: 2322033
[No Abstract] [Full Text] [Related]
28. [Polyhemoglobin-based model of an artificial oxygen carrier with functional properties similar to blood].
Khachatur'ian AA; Shlimak VM; Azhigirova MA; Viazova EP; Zeĭnalov AM
Biull Eksp Biol Med; 1981 Mar; 91(3):311-3. PubMed ID: 7248504
[TBL] [Abstract][Full Text] [Related]
29. Preparation and in vitro characteristics of a blood substitute based on pyridoxylated polyhemoglobin.
Keipert PE; Chang TM
Appl Biochem Biotechnol; 1984; 10():133-41. PubMed ID: 6524922
[TBL] [Abstract][Full Text] [Related]
30. Polyethylene Glycol Camouflaged Earthworm Hemoglobin.
Jani VP; Jelvani A; Moges S; Nacharaju P; Roche C; Dantsker D; Palmer A; Friedman JM; Cabrales P
PLoS One; 2017; 12(1):e0170041. PubMed ID: 28099525
[TBL] [Abstract][Full Text] [Related]
31. Importance of purification on transfusional efficacy of hemoglobin solutions.
Menu P; Labrude P; Grandgeorge M; Vigneron C
Int J Artif Organs; 1991 Oct; 14(10):672-5. PubMed ID: 1748536
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of SNO-PEG-hemoglobin as a candidate for oxygen transporting material.
Nakai K; Togashi H; Yasukohchi T; Sakuma I; Fujii S; Yoshioka M; Satoh H; Kitabatake A
Int J Artif Organs; 2001 May; 24(5):322-8. PubMed ID: 11420882
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
[TBL] [Abstract][Full Text] [Related]
34. An attempt to prepare hepatitis B virus (HBV)-free plasma by ultrafiltration using microporous regenerated cellulose hollow fiber.
Sekiguchi S; Ito K; Kobayashi M; Ikeda H; Manabe S; Tsurumi T; Ishikawa G; Satani M; Yamaguchi K
Transfus Sci; 1990; 11(2):211-6. PubMed ID: 10149527
[TBL] [Abstract][Full Text] [Related]
35. The oxygen carrying capability of hemoglobin vesicles evaluated in rat exchange transfusion models.
Kobayashi K; Izumi Y; Yoshizu A; Horinouchi H; Park SI; Sakai H; Takeoka S; Nishide H; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1997 Jul; 25(4):357-66. PubMed ID: 9242931
[TBL] [Abstract][Full Text] [Related]
36. Possible importance of chromatographic purification position in a blood substitute elaboration process.
Menu P; Faivre B; Labrude P; Grandgeorge M; Vigneron C
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):443-5. PubMed ID: 1391461
[TBL] [Abstract][Full Text] [Related]
37. In vivo evaluation of a pyridoxylated-hemoglobin-polyoxyethylene conjugate.
Matsushita M; Yabuki A; Malchesky PS; Harasaki H; Nosé Y
Biomater Artif Cells Artif Organs; 1988; 16(1-3):247-60. PubMed ID: 3179467
[TBL] [Abstract][Full Text] [Related]
38. Reduction of HTLV-I-infected cells in blood by leukocyte filtration.
Al EJ; Visser SC; Broersen SM; Stienstra S; Huisman JG
Ann Hematol; 1993 Dec; 67(6):295-300. PubMed ID: 8280813
[TBL] [Abstract][Full Text] [Related]
39. Subcutaneous microvascular responses to hemodilution with a red cell substitute consisting of polyethyleneglycol-modified vesicles encapsulating hemoglobin.
Sakai H; Tsai AG; Kerger H; Park SI; Takeoka S; Nishide H; Tsuchida E; Intaglietta M
J Biomed Mater Res; 1998 Apr; 40(1):66-78. PubMed ID: 9511100
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of hemoglobin-polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid.
Iwasaki K; Iwashita Y; Ikeda K; Uematsu T
Artif Organs; 1986 Dec; 10(6):470-4. PubMed ID: 3800703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
